The investment is made with GoCo Health Innovation City at AstraZeneca in Mölndal as a base. A life science cluster in growth where business and academia are already working closely together. GoCo Active establishes a collaboration platform that will contribute with research-based knowledge, both to strengthen the health of the public and to give elite athletes the best possible conditions.
"GoCo Active will create an arena for collaboration and interaction between researchers, students, athletes and the general public”, says Stefan Bengtsson, President and CEO of Chalmers University of Technology.
“As a National Sports University, and with research at the intersection between health and technology, Chalmers’ profile is ideally suited to the aims of the project. Contributing to improving health and development in this area feels like an important and exciting prospect.”
GoCo Active will serve as a meeting place in a new building directly adjacent to GoCo's other venture in Mölndal. A digital platform will also be created.
"We need to meet the health issues in society with new technologies, innovative solutions and new knowledge," says Martin Fagerström, assistant professor and active in Chalmers' Area of Advance Health Engineering.
"Tomorrow's health care is developing right now and it is happening at the intersection of researchers, practitioners in healthcare, business and individuals in need of care. This research is an important part of Chalmers' contribution to this collaboration."
In addition to Chalmers, the University of Gothenburg and Henrik Lundqvist, Next step group, Vectura Fastigheter, Balder and AstraZeneca are behind the initiative.
In the upper picture: Stefan Bengtsson, principal and CEO of Chalmers. Photo: Anna-Lena Lundqvist.
In the bottom picture: Martin Fagerström, assistant professor and Co-director of Area of Advance Health Engineering, and Henrik Lundqvist. Photo: GoCo Health Innovation City